Enrique Poradosu - Jan 12, 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chief Science & Business Off
Signature
/s/ Enrique Poradosu
Stock symbol
NVCT
Transactions as of
Jan 12, 2023
Transactions value $
$0
Form type
4
Date filed
1/13/2023, 04:05 PM
Previous filing
May 16, 2022
Next filing
Mar 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Award $0 +115K +9.14% $0.00 1.37M Jan 12, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units will vest according to the following schedule: one-third on each of 01/12/2024, 01/12/2025, and 01/12/2026.
F2 Includes 48,399 shares of restricted stock and 175,000 restricted stock units.